信星集團(01170.HK)授出合共300萬份購股權及290萬股獎勵股份
格隆匯12月12日丨信星集團(01170.HK)宣佈,於2022年12月12日,公司根據公司於2022年8月26日採納的購股權計劃,向承授人授予300萬份購股權以認購公司股本中每股面值0.10港元的普通股,作為獎勵購股權承授人對本集團之持續營運及發展所作出的貢獻。於合共300萬份購股權中,其中195萬份購股權乃授予公司董事,而餘下之105萬份購股權則授予集團其他僱員,
於2022年12月12日,董事會根據公司薪酬委員會的推薦意見,議決根據股份獎勵計劃無償向31名股份獎勵承授人授出合共290萬股獎勵股份,全部由公司現有股份撥付,並已由受託人動用公司向受託人提供的內部資源於公開市場上收購,惟須待股份獎勵承授人接納方可作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.